$KGKG
KONA GOLD BEVERAGE, INC. Stock $kgkg

$kgkg Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017082 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$929.5K	$1.275M
YoY Change	-20.78%	28.11%
Cost Of Revenue	$742.7K	$986.9K
YoY Change	-16.13%	16.12%
Gross Profit	$186.8K	$288.0K
YoY Change	-35.1%	98.3%
Gross Profit Margin	20.1%	22.59%
Selling, General & Admin	$927.7K	$1.274M
YoY Change	-10.06%	35.62%
% of Gross Profit	496.55%	442.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$26.80K	$24.03K
YoY Change	16.78%	-8.21%
% of Gross Profit	14.34%	8.34%
Operating Expenses	$927.7K	$1.274M
YoY Change	-10.06%	35.62%
Operating Profit	-$740.9K	-$985.9K
YoY Change	-0.37%	24.16%
Interest Expense	$309.4K	$293.6K
YoY Change	97.73%	-31.86%
% of Operating Profit
Other Income/Expense, Net	$5.037K	$131.00
YoY Change	180.14%	-95.94%
Pretax Income	-$1.535M	-$1.593M
YoY Change	10.38%	-55.33%
Income Tax
% Of Pretax Income
Net Earnings	-$1.535M	-$1.593M
YoY Change	10.52%	-55.28%
Net Earnings / Revenue	-165.09%	-124.92%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	2228B shares	2.139B shares
Diluted Shares Outstanding	2.231B shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$97.16K	$76.61K
YoY Change	1469.63%	-74.19%
Cash & Equivalents	$97.16K	$76.61K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$551.8K	$643.0K
Prepaid Expenses
Receivables	$24.25K	$13.14K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$673.2K	$732.7K
YoY Change	-47.45%	-53.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$306.1K	$325.7K
YoY Change	-6.67%	-5.72%
Goodwill
YoY Change
Intangibles	$61.32K	$63.76K
YoY Change	-13.72%	-13.27%
Long-Term Investments
YoY Change
Other Assets	$7.100K	$13.35K
YoY Change	-53.07%	-11.76%
Total Long-Term Assets	$838.9K	$1.111M
YoY Change	-34.71%	-17.83%
TOTAL ASSETS
Total Short-Term Assets	$673.2K	$732.7K
Total Long-Term Assets	$838.9K	$1.111M
Total Assets	$1.512M	$1.844M
YoY Change	-41.07%	-36.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.643M	$1.587M
YoY Change	92.36%	48.03%
Accrued Expenses	$407.2K	$363.5K
YoY Change	-8.24%	-27.44%
Deferred Revenue
YoY Change
Short-Term Debt	$689.0K	$629.4K
YoY Change	713.12%	-3.55%
Long-Term Debt Due	$2.962M	$2.517M
YoY Change	53.73%	629.73%
Total Short-Term Liabilities	$6.358M	$5.751M
YoY Change	51.29%	27.74%
LONG-TERM LIABILITIES
Long-Term Debt	$58.01K	$58.00K
YoY Change	161.07%	-95.78%
Other Long-Term Liabilities	$332.6K	$579.2K
YoY Change	-45.18%	-5.88%
Total Long-Term Liabilities	$390.6K	$637.2K
YoY Change	-35.62%	3.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.358M	$5.751M
Total Long-Term Liabilities	$390.6K	$637.2K
Total Liabilities	$6.749M	$6.388M
YoY Change	21.45%	-12.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.74M	-$25.21M
YoY Change	25.84%	26.91%
Common Stock	$22.95K	$21.39K
YoY Change	34.28%	44.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.237M	-$4.545M
YoY Change
Total Liabilities & Shareholders Equity	$1.512M	$1.844M
YoY Change	-41.07%	-36.7%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$1.535M	-$1.593M
YoY Change	10.52%	-55.28%
Depreciation, Depletion And Amortization	$26.80K	$24.03K
YoY Change	16.78%	-8.21%
Cash From Operating Activities	-$369.7K	-$215.5K
YoY Change	-61.08%	-67.81%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	390.3K	$252.4K
YoY Change	-41.07%	-11.01%
NET CHANGE
Cash From Operating Activities	-369.7K	-$215.5K
Cash From Investing Activities	0.000
Cash From Financing Activities	390.3K	$252.4K
Net Change In Cash	20.54K	$36.82K
YoY Change	-107.07%	-109.05%
FREE CASH FLOW
Cash From Operating Activities	-$369.7K	-$215.5K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$369.7K	-$215.5K
YoY Change	-60.95%	-68.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001802546
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	KGKG	Financing Cost Expense FinancingCostExpense		usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023Q1	KGKG	Stock Issued During Period Value Common Stock Issued Upon Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCommonStockIssuedUponCashlessExerciseOfWarrants		usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022Q1	KGKG	Preferred Stock Issued For Common Stock Issuable PreferredStockIssuedForCommonStockIssuable		usd
CY2022Q1	KGKG	Fair Value Of Warrants Issued For Financing Costs FairValueOfWarrantsIssuedForFinancingCosts		usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023Q1	KGKG	Gain On Change In Fair Value Of Derivative Liabilities GainOnChangeInFairValueOfDerivativeLiabilities		usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2022Q1	KGKG	Increase Decrease In Deposit IncreaseDecreaseInDeposit		usd
CY2023Q1	KGKG	Payments For Proceeds From In Intellectual Property PaymentsForProceedsFromInIntellectualProperty		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	KGKG	Noncash Recording Of Right Of Use Asset And Lease Liability NoncashRecordingOfRightOfUseAssetAndLeaseLiability		usd
CY2022Q1	KGKG	Fair Value Of Warrants Issued Upon Issuance Of Convertible Notes FairValueOfWarrantsIssuedUponIssuanceOfConvertibleNotes		usd
CY2023Q1	KGKG	Lessee Operating Lease Liability Payments Due Year Four And Thereafter LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023Q1	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-56230
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	KONA GOLD BEVERAGE, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1915692
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	746 North Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32934
CY2023Q1	dei	City Area Code CityAreaCode	(844)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	714-2224
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	KGKG
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2227929544060	shares
CY2023Q1	us-gaap	Cash Cash	76609	usd
CY2022Q4	us-gaap	Cash Cash	39788	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	143906	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	145579	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13135	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	79529	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	642998	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	859179	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45262	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	732742	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1023758	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	325683	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348064	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	707997	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	762464	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	63762	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	66201	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	13350	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15125	usd
CY2023Q1	us-gaap	Assets Assets	1843534	usd
CY2022Q4	us-gaap	Assets Assets	2215612	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1587187	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1379227	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	162083	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	137083	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	654403	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	659550	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	201384	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	209685	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	629378	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	411060	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5751339	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5294755	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	57999	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	57055	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	579148	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	629197	usd
CY2023Q1	us-gaap	Liabilities Liabilities	6388486	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5981007	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5702000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5702000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	989000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	989000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2139440557	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2139440557	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2000276378	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2000276378	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	21394	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	20003	usd
CY2023Q1	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	169999860	shares
CY2022Q4	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	169999860	shares
CY2023Q1	KGKG	Common Stock Issuable CommonStockIssuable	1386489	usd
CY2022Q4	KGKG	Common Stock Issuable CommonStockIssuable	1386497	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19252920	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18441303	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25205765	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23613208	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4544952	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3765395	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1843534	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2215612	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1274897	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	995131	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	986859	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	849876	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	288038	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	145225	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1273961	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	939336	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-985923	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-794081	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	293591	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	430895	usd
CY2023Q1	KGKG	Financing Cost Expense FinancingCostExpense	163000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1793000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-150174	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-546810	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	131	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3224	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1592557	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3561562	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2083977870	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1162096383	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3765395	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	315000	usd
CY2023Q1	KGKG	Adjustments To Additional Paid In Capital Warrants Related To Convertible Note AdjustmentsToAdditionalPaidInCapitalWarrantsRelatedToConvertibleNote	150000	usd
CY2023Q1	KGKG	Adjustments To Additional Paid In Capital Warrants Issued For Financing Costs AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedForFinancingCosts	163000	usd
CY2023Q1	KGKG	Stock Issued During Period Value Preferred Stock Conversion To Common Stock StockIssuedDuringPeriodValuePreferredStockConversionToCommonStock	185000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1592557	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4544952	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3189414	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	135000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3561562	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4362006	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4362006	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1592557	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3561562	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21591	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23744	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1673	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-8366	usd
CY2023Q1	KGKG	Rightofuse Asset Amortization RightofuseAssetAmortization	54467	usd
CY2022Q1	KGKG	Rightofuse Asset Amortization RightofuseAssetAmortization	49210	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	250917	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	367845	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2439	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2439	usd
CY2023Q1	KGKG	Preferred Stock Issued For Common Stock Issuable PreferredStockIssuedForCommonStockIssuable	-185000	usd
CY2023Q1	KGKG	Fair Value Of Warrants Issued For Financing Costs FairValueOfWarrantsIssuedForFinancingCosts	163000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-790	usd
CY2023Q1	KGKG	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt	192648	usd
CY2022Q1	KGKG	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt	546810	usd
CY2022Q1	KGKG	Gain On Change In Fair Value Of Derivative Liabilities GainOnChangeInFairValueOfDerivativeLiabilities	-1793000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-68067	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	69770	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-216181	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	554481	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-267342	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-45262	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1564	usd
CY2023Q1	KGKG	Increase Decrease In Deposit IncreaseDecreaseInDeposit	-1775	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	207960	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	571666	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	25000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-50000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-56411	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-48945	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-215544	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-669504	usd
CY2022Q1	KGKG	Payments For Proceeds From In Intellectual Property PaymentsForProceedsFromInIntellectualProperty	21131	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21131	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	80000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	81500	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1500	usd
CY2023Q1	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	5147	usd
CY2022Q1	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	3224	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1939	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1899	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	284595	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	292219	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	424644	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1994	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	401000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	252365	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	283602	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	36821	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-407033	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39788	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	703825	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	76609	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	296792	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	3923	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	130	usd
CY2022Q1	KGKG	Noncash Recording Of Right Of Use Asset And Lease Liability NoncashRecordingOfRightOfUseAssetAndLeaseLiability	135000	usd
CY2023Q1	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest	315000	usd
CY2022Q1	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest	3189414	usd
CY2023Q1	KGKG	Fair Value Of Warrants Issued Upon Issuance Of Convertible Notes FairValueOfWarrantsIssuedUponIssuanceOfConvertibleNotes	150000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1592557	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-215544	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4544952	usd
CY2023Q1	us-gaap	Cash Cash	76609	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	230000	usd
CY2023Q1	KGKG	Payments For Advance To Refinancing PaymentsForAdvanceToRefinancing	234965	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	52519	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	325683	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348064	usd
CY2022Q4	KGKG	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	57055	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.004
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	31531	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	85000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zztNdcaHPn7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zH7OPV3bMEG">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	143906	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	145579	usd
CY2023Q1	KGKG	Sales Percentage SalesPercentage	0.03	pure
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1274897	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	995131	usd
CY2023Q1	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	0.28	pure
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1274897	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	995131	usd
CY2023Q1	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	0.28	pure
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	18966	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-03-07
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1477051088	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1696611077	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1477051088	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1696611077	shares
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zIC8zC98U3sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zaVm1kt9rcTg">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cash balances on deposit with banks are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20230331_zlpiatMIDJs2" title="Cash FDIC insured amount">250,000</span>. Generally, the Company’s policy is to minimize borrowing costs by immediately applying cash receipts to borrowings against its credit facility. From time to time, however, the Company may be exposed to risk for the amounts of funds held in bank accounts in excess of the FDIC limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross sales.</i> During the three months ended March 31, 2023, the Company reported no customers that accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zDybhfLJdYZ" title="Concentration risk, percentage">10</span>% of gross sales. During the three months ended March 31, 2022, the Company reported no customers that accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zjlEeqN5p2rd" title="Concentration risk, percentage">10</span>% of gross sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of March 31, 2023, the Company had accounts receivable from five customers that comprised <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zs851eUiRBO8" title="Concentration risk percentage">25</span>%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zVzNY1sEC4dg" title="Concentration risk percentage">18</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zdsatTxIeEza" title="Concentration risk percentage">11</span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zuniMiWyfBp7" title="Concentration risk percentage">11</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_z6wi7FGaMEq3" title="Concentration risk percentage">10</span>%, respectively, of its gross accounts receivable. As of December 31, 2022, the Company had accounts receivable from two customers that comprised <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z4WTPpMiu2x2" title="Concentration risk percentage">27</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zprpY8KDLsh7" title="Concentration risk percentage">20</span>%, respectively, of its gross accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Co-Packers. </i>The raw materials used in the production of the Company’s products are obtained by the Company’s co-packers and consist primarily of materials such as the flavors, caffeine, sugars or sucralose, taurine, vitamins, CBD, and hemp seed protein contained in its beverages, the bottles in which its beverages are packaged, and the labeling on the outside of its beverages. These principal raw materials are subject to price and availability fluctuations. The Company currently relies on a few key co-packers, which in turn rely on a few key suppliers. The Company continually endeavors to have back-up co-packers, which co-packers would in turn depend on their third-party suppliers to supply certain of the flavors and concentrates that are used in the Company’s beverages. The Company is also dependent on these co-packers to negotiate arrangements with their existing suppliers that would enable the Company to obtain access to certain of such concentrates or flavor formulas under certain extraordinary circumstances. Additionally, in a limited number of cases, the Company’s co-packers may have contractual restrictions with their suppliers or the Company’s co-packers may need to obtain regulatory approvals and licenses that may limit the co-packers’ ability to enter into agreements with alternative suppliers. Contractual restrictions in the agreements the Company has with certain distributors may also limit the Company’s ability to enter into agreements with alternative distributors. The Company believes that a satisfactory supply of co-packers will continue to be available at competitive prices, although there can be no assurance in this regard. With respect to Gold Leaf’s operations, the Company continually endeavors to contract with additional beverage vendors to ensure the Company has adequate inventory. The Company believes that a satisfactory supply of vendors will continue to be available at competitive prices, although there can be no assurance in this regard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the three months ended March 31, 2023, the Company’s largest three vendors accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zQNEr12IlLl5">68</span>% of all purchases, respectively. During the year ended December 31, 2022, the Company’s largest one vendor accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zXNzPO6K6OBl">34</span>% of all purchases, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable.</i> As of March 31, 2023, two vendors accounted for more than <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--TwoVendorMember_zymsK9I9nce2" title="Concentration risk, percentage">10</span>% the total accounts payable. The Company’s largest two vendors accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zOfug3SpcD5d">27</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorTwoMember_z1w5f6Ky7hLc">21</span>% of the total accounts payable, respectively. As of December 31, 2022, two vendors accounted for more than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--TwoVendorMember_zDH21xjiBFy8" title="Concentration risk, percentage">10</span>% the total accounts payable. The Company’s largest two vendors accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zU6N52mp0Fce">31</span>%, and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorTwoMember_zKS1CXAcOuHf">18</span>% of the total accounts payable, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	195389	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	198605	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	447609	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	660574	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	642998	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	859179	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	542362	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	543152	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	216679	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	195088	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	989000	shares
CY2023Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	85340	usd
CY2022Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	85340	usd
CY2023Q1	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks	12200	usd
CY2022Q4	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks	12200	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	33778	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	31339	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	63762	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	66201	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2439	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2439	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	7315	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9754	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9754	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9754	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9754	usd
CY2023Q1	KGKG	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	17431	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	63762	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	847986	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	988035	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	57234	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	218481	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	790752	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	769554	usd
CY2023Q1	KGKG	Notes Payable Current Portion NotesPayableCurrentPortion	732753	usd
CY2022Q4	KGKG	Notes Payable Current Portion NotesPayableCurrentPortion	712499	usd
CY2023Q1	KGKG	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	57999	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	31531	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	419213	usd
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	989000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2023Q1	us-gaap	Lease Cost LeaseCost	54467	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	49210	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	762464	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	54467	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	707997	usd
CY2022Q4	KGKG	Lease Liabilities LeaseLiabilities	838882	usd
CY2022Q4	KGKG	Finance Lease Liabilities FinanceLeaseLiabilities	17824	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	821058	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1939	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	56411	usd
CY2023Q1	KGKG	Lease Liabilities LeaseLiabilities	780532	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	201384	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	579148	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M19D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1000	pure
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0209	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	203848	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	262715	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	261083	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	198217	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	925863	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	145331	usd
CY2023Q1	KGKG	Present Value Of Net Minimum Lease Payments PresentValueOfNetMinimumLeasePayments	780532	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	201384	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	579148	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2139440557	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2139440557	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2000276378	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2000276378	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	278333333	shares
CY2022Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.0223
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	136000000	shares
CY2023Q1	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0045
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	67164179	shares
CY2023Q1	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0045
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	347169154	shares
CY2023Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.0188
CY2023Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	347169154	shares
CY2023Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Weighted Average Exercisable Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsWeightedAverageExercisablePrice	0.0188
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	347169154	shares
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y11M8D
CY2023Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Outstanding Non Options Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNonOptionsWeightedAverageExercisePrice	0.0188
CY2023Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	347169154	shares
CY2023Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	0.0188
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.0032

Files In Submission

Name	View Source	Status
0001493152-23-017082-index-headers.html	Edgar Link	pending
0001493152-23-017082-index.html	Edgar Link	pending
0001493152-23-017082.txt	Edgar Link	pending
0001493152-23-017082-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
kgkg-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
kgkg-20230331_cal.xml	Edgar Link	unprocessable
kgkg-20230331_def.xml	Edgar Link	unprocessable
kgkg-20230331_lab.xml	Edgar Link	unprocessable
kgkg-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KGKG
KONA GOLD BEVERAGE, INC. Stock $kgkg

2023 Q2 Form 10-Q Financial Statement

#000149315223017082 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG KONA GOLD BEVERAGE, INC. Stock $kgkg

2023 Q2 Form 10-Q Financial Statement

#000149315223017082 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG
KONA GOLD BEVERAGE, INC. Stock $kgkg